Search clinical trials for: RAD001, Capecitabine, Oxaliplatin

Total 3531 results

Odonate Therapeutics, Inc.

Terminated

Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC (CONTESSA)

Breast Cancer

Korea, Republic of, United States, Spain, Canada, Singapore, Taiwan, Australia, Belgium, Thailand, Hungary, Germany, United Kingdom, France, Ukraine, Austria, Czechia, Italy, Poland, Russian Federation
Taiho Oncology, Inc.
Quintiles, Inc.

Completed

A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors

Neoplasms

United States
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Bioequivalence Study of Capecitabine Tablets

Metastatic Breast Cancer or Metastatic Colorectal Cancer

China
University of Pittsburgh
Sanofi

Completed

Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
Tianjin Medical University Cancer Institute and...

Completed

Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer

Neurotoxicity

China
Peking University Cancer Hospital & Institute

Unknown

Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)

Biliary Tract Cancer

China
Asan Medical Center
Bayer

Completed

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

Effects of Chemotherapy | Malignant Neoplasm of Stomach

Korea, Republic of
Dutch Colorectal Cancer Group
Sanofi; Hoffmann-La Roche; Koningin Wilhelmina Fonds

Completed

Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma

Advanced Colorectal Cancer
Fudan University

Recruiting

Metronomic Capecitabine in Stage III Gastric Cancer

Gastric Cancer

China
Korea University Anam Hospital

Not yet recruiting

Combination of Nelmastobart and Capecitabine Therapy in Metastatic Colorectal Cancer

Recurrent or Metastatic Colorectal Cancer
Jonsson Comprehensive Cancer Center
Eli Lilly and Company

Completed

LY317615 Plus Capecitabine in Treating Patients With Advanced Solid Tumors

Solid Tumor | Adult

United States
PharmaMar

Completed

Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).

Metastatic Colorectal Cancer | Pancreatic Cancer | Metastatic Breast Cancer

Spain, Belgium
Daiichi Sankyo, Inc.

Completed

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
PhytoCeutica

Completed

Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma | Liver Cancer

United States, Taiwan
Novartis Pharmaceuticals

Completed

A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Lymphangioleiomyomatosis

France, United States, Italy
NYU Langone Health

Completed

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

Neurofibromatosis Type 2 | Meningiomas | Vestibular Schwannomas

United States
Novartis Pharmaceuticals

Completed

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Renal Cell Carcinoma

South Africa, Egypt, Saudi Arabia, Russian Federation, Lebanon, Thailand, Jordan, India, Tunisia, Algeria
Seoul National University Hospital

Completed

Study of RAD001 in Adenoid Cystic Carcinoma (ACCRAD001)

Adenoid Cystic Carcinoma

Korea, Republic of
Austin Health

Unknown

Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol (RADiChol)

Cholangiocarcinoma

Australia
Sheba Medical Center

Unknown

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Prostate Cancer

Israel
Novartis Pharmaceuticals

Completed

Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy (PILLAR-1)

Lymphoma, Mantle- Cell

United States
Novartis Pharmaceuticals

Completed

Treatment of Patients With RAD001 With Progressive Sarcoma

Progressive Sarcoma

Germany, Italy
Emory University

Completed

Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
Novartis Pharmaceuticals

Completed

Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma (RECORD-4)

Metastatic Renal Cell Carcinoma

China, Argentina, Brazil, Russian Federation, Bulgaria, United States
The Methodist Hospital Research Institute
Novartis

Completed

Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer (RAD001)

Carcinoma, Renal Cell

United States
Daniel George, MD
Novartis Pharmaceuticals

Completed

RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer

Hormone Refractory Prostate Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center

Completed

RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Asan Medical Center
Novartis

Completed

RAD001 in Advanced Sarcoma

Soft Tissue Sarcomas | Bone Sarcomas

Korea, Republic of
Novartis Pharmaceuticals

Completed

Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients

Non Small Cell Lung Cancer

Australia, Germany, United States
Cliniques universitaires Saint-Luc- Université...

Completed

A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

Transitional Cell Carcinoma

Belgium
Swedish Medical Center
Novartis

Completed

Phase II Trial of RAD001 in Refractory Colorectal Cancer

Colorectal Cancer

United States
Shanghai General Hospital, Shanghai Jiao Tong University...

Not yet recruiting

Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal Cancer

Colorectal Carcinoma
Fudan University

Not yet recruiting

Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy

Colorectal Cancer | Colorectal Cancer Stage IV
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
University of Rochester

Recruiting

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

Breast Cancer

United States
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC

Esophageal Squamous Cell Carcinoma

China
Sanofi

Completed

Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

Cancer | Breast Cancer

United States, France
Cancer Institute and Hospital, Chinese Academy...

Unknown

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Metastatic Breast Cancer

China
Alaunos Therapeutics

Unknown

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

Advanced Solid Tumors

United States
Peking University Cancer Hospital & Institute
Roche Pharma AG

Unknown

Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis

Gastric Cancer

China
National Cancer Center, Korea

Unknown

S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer

Stomach Neoplasms

Korea, Republic of
Aga Khan University

Completed

Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC) (HCC-CAP)

Carcinoma, Hepatocellular

Pakistan
James A. Haley Veterans Administration Hospital
Hoffmann-La Roche

Terminated

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

Cancer of Liver

United States
China Medical University, China

Terminated

A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer

Stomach Neoplasms

China
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of SA001 in Healthy Male Volunteers

Healthy

Korea, Republic of
Canadian Cancer Trials Group
Alliance for Clinical Trials in Oncology; NRG Oncology; ECOG-ACRIN Cancer Research... and other collaborators

Not yet recruiting

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer (NEO-RT)

Rectal Cancer

United States
Merck Sharp & Dohme LLC

Active, not recruiting

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

Gastric Neoplasms | Gastroesophageal Junction Adenocarcinoma

United States, Australia, Brazil, Chile, China, France, Germany, Guatemala, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
Peking University Cancer Hospital & Institute

Completed

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

Rectal Cancer

China
Hoffmann-La Roche

Completed

A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.

Gastric Cancer

Spain
Royal Marsden NHS Foundation Trust
Roche Pharma AG

Completed

Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer

Metastatic Colorectal Cancer

United Kingdom

Search clinical trials for: RAD001, Capecitabine, Oxaliplatin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations